A C-Terminal Heat Shock Protein 90 Inhibitor Decreases Hyperglycemia-induced Oxidative Stress and Improves Mitochondrial Bioenergetics in Sensory Neurons by Zhang, Liang et al.
A C-Terminal Heat Shock Protein 90 Inhibitor Decreases
Hyperglycemia-induced Oxidative Stress and Improves
Mitochondrial Bioenergetics in Sensory Neurons
Liang Zhang#, Huiping Zhao^, Brian S.J. Blagg^, and Rick T. Dobrowsky#,*
#Department of Pharmacology and Toxicology, The University of Kansas, Lawrence, KS 66045
^Department of Medicinal Chemistry, The University of Kansas, Lawrence, KS 66045
Summary
Diabetic peripheral neuropathy (DPN) is a common complication of diabetes in which
hyperglycemia-induced mitochondrial dysfunction and enhanced oxidative stress contribute to
sensory neuron pathology. KU-32 is a novobiocin-based, C-terminal inhibitor of the molecular
chaperone, heat shock protein 90 (Hsp90). KU-32 ameliorates multiple sensory deficits associated
with the progression of DPN and protects unmyelinated sensory neurons from glucose-induced
toxicity. Mechanistically, KU-32 increased the expression of Hsp70 and this protein was critical
for drug efficacy in reversing DPN. However, it remained unclear if KU-32 had a broader effect
on chaperone induction and if its efficacy was linked to improving mitochondrial dysfunction.
Using cultures of hyperglycemically stressed primary sensory neurons, the present study
investigated whether KU-32 had an effect on the translational induction of other chaperones and
improved mitochondrial oxidative stress and bioenergetics. A variation of stable isotope labeling
with amino acids in cell culture called pulse SILAC (pSILAC) was used to unbiasedly assess
changes in protein translation. Hyperglycemia decreased the translation of numerous
mitochondrial proteins that affect superoxide levels and respiratory activity. Importantly, this
correlated with a decrease in mitochondrial oxygen consumption and an increase in superoxide
levels. KU-32 increased the translation of Mn superoxide dismutase and several cytosolic and
mitochondrial chaperones. Consistent with these changes, KU-32 decreased mitochondrial
superoxide levels and significantly enhanced respiratory activity. These data indicate that efficacy
of modulating molecular chaperones in DPN may be due in part to improved neuronal
mitochondrial bioenergetics and decreased oxidative stress.
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Diabetic peripheral neuropathy (DPN) is a neurodegenerative complication of diabetes that
develops in 50–60% of diabetic patients1. DPN has proven difficult to manage
pharmacologically since it does not result from a single biochemical etiology that is
manifested uniformly for the disease’s duration (10 – 30 yrs). Molecular targets that are
relatively “diabetes specific” (polyol & hexosamine pathways, advanced glycation end
products) or which are altered in numerous disease states (PKC activation, altered
neurotrophic support, enhanced oxidative stress) contribute to the progressive degeneration
of small and large sensory fibers in DPN 2. However, current small molecule inhibitors of
the above pathways/products have yielded few therapeutic agents. Clearly, the rational
identification of new molecular paradigms that ameliorate DPN and offer “druggable”
targets affords translational potential for improving the medical management of DPN.
Many neurodegenerative diseases fall into a class of protein-conformational disorders since
their etiology is linked to the accumulation of specific mis-folded or aggregated proteins (for
example, β-amyloid & tau in Alzheimer’s disease)3. Though the etiology of DPN is not
causally linked to the accrual of any one specific mis-folded or aggregated protein,
hyperglycemia can increase oxidative stress4. The oxidative modification of amino acids5, 6
can impair protein folding3, decrease mitochondrial function and protein import2, 5, 7 and
increase interaction with molecular chaperones8.
Molecular chaperones such as heat shock proteins 90 and 70 (Hsp90, Hsp70) are critical to
folding nascent proteins. However, both of these chaperones are components of the cellular
heat shock response (HSR). Numerous conditions that promote cell stress lead to the Hsp90-
dependent induction of the HSR which, in part, promotes the transient up-regulation of
Hsp70 to aid the refolding or clearance of aggregated and damaged proteins8. Hsp70
upregulation can also prevent neuronal apoptosis9 and decrease oxidative stress in
neurodegenerative disorders10. Importantly, the HSR can be pharmacologically activated by
inhibiting Hsp90 and we have developed and validated KU-32 as a novel, novobiocin-based,
C-terminal Hsp90 inhibitor11, 12 that protects against in vitro neuronal cell death 13, 14.
KU-32 also effectively reversed pre-existing psychosensory and electrophysiologic deficits
of DPN in mice and its efficacy required Hsp70 as the drug was ineffective at reversing
DPN modeled in Hsp70.1 and Hsp70.3 double knockout mice15. While these data clearly
support that modulating molecular chaperones offers a potentially novel approach toward
treating sensory neuron dysfunction in DPN, additional insight into the mechanism by which
KU-32 may improve the function of glycemically stressed neurons is needed.
Increased oxidative stress and mitochondrial dysfunction are strongly implicated in the
pathogenesis of DPN5, 16. Using variations of stable isotope labeling of amino acids in
culture (SILAC), we have recently shown that numerous mitochondrial proteins are
downregulated in response to hyperglycemia in cultured primary Schwann cells and dorsal
root ganglia obtained from diabetic rats17, 18. Importantly, decreases in the mitochondrial
proteome correlated with a decrease in mitochondrial respiratory capacity18. However, as
the level of all proteins is affected by the balance between their rates of synthesis versus
degradation, these studies provided no insight into possible effects of hyperglycemia on the
rate of protein translation. Indeed, little is known regarding the effect of hyperglycemia on
rates of protein translation in sensory neurons.
In the present study, we took an unbiased approach to address the effect of hyperglycemia
on protein translation using pulse SILAC (pSILAC)19. Moreover, since the mechanism of
KU-32 invokes an increase in chaperone translation, we assessed the effect of
hyperglycemia and KU-32 treatment on translation of mitochondrial proteins in sensory
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neurons. We identify that hyperglycemia decreases the translation of numerous
mitochondrial proteins and this correlates with an increase in mitochondrial superoxide
levels and a decrease in mitochondrial respiratory function. KU-32 increased the overall rate
of protein translation in glycemically stressed neurons, including several cytosolic and
mitochondrial chaperones, components of the mitochondrial respiratory chain and Mn
superoxide dismutase (MnSOD). Importantly, these changes correlated with a decrease in
mitochondrial superoxide levels and increased mitochondrial respiratory capacity.
Collectively, these data suggest that KU-32 may improve the sensory deficits associated
with DPN by enhancing chaperone levels and improving mitochondrial function.
Experimental Procedures
Preparation of Embryonic Dorsal Root Ganglion Sensory Neurons
Dorsal root ganglion (DRG) neurons were dissected from embryonic day 15–18 rat pups and
the ganglia were collected into L15 medium20. The tissue was dissociated with 0.25%
trypsin at 37°C for 30 min, the cells resuspended in DMEM containing 25 mM glucose, 10%
fetal calf serum (FCS, Atlas Biologicals, Fort Collins, CO) and triturated with a firepolished
glass pipette. The cells were counted and plated in the center of collagen coated (0.1 mg/mL
collagen followed by overnight air drying in a laminar flow hood) 35 mm dishes at a density
of 2–3 × 105 cells per dish. The cells were cultured in maintenance medium composed of
DMEM (4.5 mg/ml glucose, 25 mM) containing 10% dialyzed FCS, 1× penicillin/
streptomycin, 1X gentamicin and 50 ng/ml NGF (Harlan Biosciences, Indianapolis, IN). To
remove proliferating cells, the neurons were treated with 10 µM each of fluorodeoxyuridine
and cytosine β-D-arabinoside for two days and the drugs withdrawn for 2 days; this cycle
was repeated two more times. As the basal glucose concentration in the culture medium was
25 mM, hyperglycemia was induced by the addition of 20 mM excess glucose as we and
others have described previously15, 21, 22. All animal procedures were performed in
accordance with protocols approved by the Institutional Animal Care and Use Committee
and in compliance with standards and regulations for care and use of laboratory rodents set
by the National Institutes of Health.
[3H]Leucine Pulse
To assess the global effect of hyperglycemia and KU-32 on protein translation, neurons
were seeded in 12 well plates at 1×105 cells per well and treated for 5 days in the absence or
presence of 20 mM excess glucose. During the final 24 hr of the incubation, the cells were
treated with DMSO or 1 µM KU-32 and pulsed with 1 µCi/ml L-[2,3,4,5-3H]Leucine
(American Radiolabeled Chemicals, St. Louis MO). The cells were washed with ice-cold
phosphate-buffered saline (PBS), scraped into 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1
mM EDTA, 1% NP-40, 1× Complete® protease inhibitors (Roche Diagnostics, Indianapolis,
IN) and an aliquot removed for protein determination. Equal amounts of total protein were
precipitated by the addition of ice cold trichloroacetic acid to a final concentration of 25%
and the precipitate was pelleted by centrifugation. The pellet was washed twice with −20°C
acetone, air dried and radioactivity quantified by scintillation spectrometry.
pSILAC Labeling
Lysine (Lys)/Arginine (Arg) deficient DMEM and isotopically enriched (>98%) [2H4] L-
Lys; [13C6] L-Arg; [13C6, 15N2] L-Lys and [13C6, 15N4] L-Arg were purchased from Sigma-
Isotec (St. Louis, MO). For each neuron preparation, we performed three different sets of
experiments to analyze the effect of hyperglycemia and KU-32 on protein translation. The
isotopic mixtures and treatments used in the pSILAC19 experiments are summarized in
Table 1. To assess the effect of hyperglycemia on translation, the neurons were cultured in
maintenance medium containing 125 mg/l 12C-Lys and 84 mg/l 12C-Arg (K0R0) in the
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absence or presence of 20 mM excess glucose for 5 days. For the final 48 hrs of the
incubation, control cultures were isotopically pulsed in DMEM supplemented with [2H4]
Lys and [13C6] Arg (K4R6) while cells subjected to hyperglycemia were pulsed in culture
medium containing [13C6, 15N2]Lys and [13C6, 15N4] Arg (K8R10). To assess the effect of
KU-32 on translation under normoglycemic conditions, the drug was added for the final 24
hrs to neurons pulsed with K8R10; cells pulsed with K4R6 received DMSO. When
assessing the effect of KU-32 on translation under hyperglycemic conditions, neurons were
maintained in medium containing 20 mM excess glucose for 5 days and 1 µM KU-32 was
added for the final 24 hrs to neurons pulsed with K4R6; DMSO was added to the cultures
pulsed with K8R10. KU-32 [N-(7-((2R,3R,4S,5R)-3,4-dihydroxy-5-methoxy-6,6-dimethyl-
tetrahydro-2H-pyran-2-yloxy)-8-methyl-2-oxo-2H-chromen-3-yl)acetamide] was
synthesized and structural purity (>95%) verified as previously described23.
At the end of the incubations, the cells were washed with ice-cold PBS and resuspended in
0.5 ml of mitochondrial isolation buffer (MIBA) containing 10 mM Tris-HCl, pH 7.4, 1 mM
EDTA, 0.2 M D-mannitol, 0.05 M sucrose, 0.5 mM sodium orthovanadate, 1 mM sodium
fluoride and 1× Complete® protease inhibitors24. The cells were homogenized and the
protein concentration of each lysate was measured in quadruplicate using the Bradford assay
and bovine serum albumin as the standard. The samples were then mixed together in a 1:1
mass ratio and the combined lysate was centrifuged at 800 × g for 10 min at 4°C. The
supernatant was recovered, a heavy mitochondrial fraction isolated by centrifugation at
8,000 × g for 5 min at 4°C and the pellet washed twice with ice-cold MIBA buffer. Three
biological replicates were performed for the MS analysis using neurons obtained from
separate litters of embyronic rat pups. Three additional biologic replicates using neurons
obtained from separate litters were performed to validate some of the MS data using
immunoblot analysis: monoclonal antibodies included Hsp70, mitochondrial Hsp70 and
Hsc70 (Stressgen/Enzo Life Sciences, Farmingdale, NY); MnSOD (Upstate Biotechnology/
Millipore, Billerica, MA) and β-actin (MP Biomedicals, Solon, OH). Hsp60 and Hsp70
protein 12A polyclonal and secondary antibodies were from Santa Cruz Biotechnology
(Santa Cruz, CA).
Mass Spectrometry and Protein Identification
Proteins were identified following one-dimensional SDS-PAGE coupled to RP-HPLC linear
quadrupole ion trap Fourier transform ion cyclotron resonance tandem mass spectrometry
(GeLC-LTQ-FT MS/MS) 25. About 50 µg of protein was fractionated by SDS-PAGE, the
proteins were visualized by staining the gel and the lanes were cut into 10–12 × 0.5 cm
sections for ingel tryptic digestion.
Tryptic digestion of the proteins was performed as described previously17, 18. The peptides
were separated on a 0.30 × 150 mm, Pepmap C18 micro-capillary reverse-phase column at a
flow rate of 5 –10 µl/min with a linear gradient from 5 to 65% acetonitrile in 0.06% aqueous
formic acid (v/v) over 65 min. The eluate was introduced into the LTQ-FT tandem mass
spectrometer (ThermoFinnigan, Waltham, MA) and mass spectra were acquired in the
positive ion mode. All experiments were performed in data-dependent mode using dynamic
exclusion with survey MS spectra (m/z 300–2000) acquired in the FT-ICR cell with
resolution R = 50,000 at m/z 400 and accumulation to a target value of 5×105 charges, or a
maximum ion accumulation time of 2000 ms. The five most intense ions were isolated and
fragmented with a target value of 2 × 103 accumulated ions and an ion selection threshold of
3000 counts. Dynamic exclusion duration was typically 180 sec with early expiration if ion
intensity fell below a S/N threshold of 2. The ESI source was operated with a spray voltage
of 2.8 kV, a tube lens offset of 130 V and a capillary temperature of 200 °C. All other source
parameters were optimized for maximum sensitivity of a synthetic YGGFL peptide ion at m/
z 556.27.
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Protein Identification and Quantification
Peak lists were acquired from the Xcalibur .raw files using MaxQuant v1.1.1.3626. Protein
identification utilized the integrated Andromeda search engine27 queried against the rat IPI
database (v3.80, 39,473 entries) that was concatenated with forward plus reverse sequences
and supplemented with common contaminants. Search parameters specified a MS tolerance
of 20 ppm, a fragment tolerance of 0.5 Da, up to 2 missed cleavages, 3 labeled amino acids
per peptide and carboxyamidomethylated cysteine as a fixed modification. Variable
modifications were set to consider methionine oxidation and protein N-terminal acetylation.
It is not necessary to specify the isotopic labels as variable modifications when using the
MaxQuant software28 but the multiplicity was set to three to consider the K4R6 and K8R10
isotope combinations.
The experimental design template of MaxQuant was constructed such that the Xcalibur .raw
MS files were grouped together for the three biological replicates (including any technical
duplicates) for each treatment group shown in Table 1. For identification, peptides were
required to be at least 6 amino acids in length and protein identification required at least one
razor plus unique peptide. A protein was only included in the final analysis if it was
identified by at least one peptide in two treatment groups. The false discovery rates were set
to 1% at the peptide and protein levels. Posterior error probabilities (PEP, false hit
probability given the peptide score and length) 26 ranged from 0 to 0.54 (95% of proteins
had a PEP < 0.05) and after mass recalibration, the average absolute mass deviation was
1.62 ppm. Annotated MS/MS spectra were derived from the .raw files using the Viewer
feature of MaxQuant.
For protein quantitation, we activated the requant feature and specified a single ratio count
of unmodified and variably modified peptides for quantitation. For all the quantified
peptides of a given protein, MaxQuant reports the median of these expression ratios and the
non-normalized ratios are reported in Supplemental Table 1. Gene ontology (GO)
annotations were obtained using the Uniprot identifier and the Perseus component of the
MaxQuant software suite. Enrichment analyses were performed using the Database for
Visualization and Integrated Discovery (DAVID) 29 and the Biological Networks Gene
Ontology (BinGO) 30 plug-in of Cytoscape 31.
Superoxide Assessment
Superoxide levels were measured by following the oxidation of dihydroethidine (Invitrogen-
Molecular Probes, Carlsbad, CA) to ethidium 32. Neurons were seeded at 1 × 104 cells per
well in black 96 well plates and were treated with 25 mM or 45 mM glucose for five days.
The cells received 1 µM KU-32 or DMSO for the final 24 hrs of the incubation and the cells
were subsequently treated with 15 µM dihydroethidine for 15 mins at 37°C. After washing
with PBS, the ratio of ethidium (excitation 530 nm, emission 590 nm) to dihydroethidine
(excitation 485 nm, emission 530 nm) was determined using a fluorescence spectrometer.
To directly assess mitochondrial superoxide production, the cells were treated as above and
washed once with phenol free Neurobasal medium. MitoTracker Green (80 nM) and 0.4 µM
MitoSOX Red were added to each well and incubated for 10 min33. The cells were washed
twice with fresh Neurobasal medium prior to imaging on an Olympus 3I Spinning Disk
confocal microscope using excitation/emission wavelengths of 575/624 nm (MitoSox Red)
and 494/531 nm (MitoTracker Green)34. As a positive control, some cells were treated with
1.8 µg/ml antimycin A for 25 mins. Fluorescence intensity of the red and green signals of at
least 200 cells per treatment was obtained using CellProfiler and CellProfiler Analyst image
analysis software.
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O2 consumption rate (OCR) was assessed using intact DRG sensory neurons and a XF96
Extracellular Flux Analyzer (Seahorse Biosciences, North Billerica, MA). Extracellular flux
analysis is a non-invasive assay which uses two calibrated optical sensors to directly
measure OCR in real-time in neurons that remain attached to the culture plate35. Primary
embryonic sensory neurons were seeded in the 96 well plates at 1.5 × 104 cells per well and
treated for 5 days in 25 mM or 45 mM glucose. Cells were treated with 1 µM KU-32 or
DMSO for the final 24 hr of the incubation and the cells were placed in fresh bicarbonate-
free DMEM containing 5 mM glucose and 1 mM pyruvate. Baseline OCR was assessed in
the XF96 analyzer using 4 measurement loops consisting of a 2 minute mix cycle and a 5
min measurement cycle. Respiratory chain inhibitors were then sequentially injected into the
wells and ATP-coupled oxygen consumption was calculated as the fraction of the basal
OCR sensitive to 1 µg/ml oligomycin, an ATP synthase inhibitor. The maximal uncoupled
respiration rate was determined by depolarizing the mitochondrial membrane potential with
1 µM FCCP (carbonylcyanide-4-(trifluoromethoxy)-phenylhydrazone). The cell seeding
density and inhibitor concentrations were optimized in preliminary experiments. After the
respiratory measures, the cells were harvested and experimental rate values were normalized
to protein content of each well. Maximal respiratory capacity, spare respiratory capacity and
respiratory state apparent (Stateapp) were determined from the rate data as described36, 37.
Statistical Analyses
All statistical differences between treatments were determined using ProStat (v4.83). Data
were analyzed using either a one-way ANOVA and Tukey’s post hoc test or a Kruskal-
Wallis test and Dunn’s post-hoc analysis.
Results and Discussion
We have shown previously that 2–3 week old cultures of embryonic sensory neurons can
serve as a cell model to examine mechanisms of hyperglycemic stress15, 21. After two weeks
in culture, embryonic sensory neurons were subjected to five days of hyperglycemia and the
global effect on protein translation was measured by pulsing the cells with [3H]Leu for the
final 24 hrs. Hyperglycemically-stressed neurons showed a 22% decrease in [3H]Leu
incorporation and treating the cells with 1 µM KU-32 for 24 hr prior to the Leu pulse
significantly increased overall translation (Fig. 1). These results suggest that modulating
chaperones may broadly increase protein translation.
To identify specific proteins whose translation was differentially effected by hyperglycemia
and KU-32, we utilized the pSILAC strategy that has been previously described19 and is
outlined in Fig. 2. To assess the effect of KU-32 on protein translation in hyperglycemically
stressed sensory neurons, neurons were incubated in K0R0 culture medium containing 45
mM glucose. After 3 days, the K0R0 cultures were divided such that one set of cells was
placed in hyperglycemic culture medium containing medium-heavy forms of Lys and Arg
(K4R6). The cells were pulsed with K4R6 for 48 hrs and treated with 1 µM KU-32 for the
final 24 hr of the incubation. The remaining K0R0 cells were placed in hyperglycemic
culture medium containing heavy isotope forms of Lys and Arg (K8R10) and treated with
DMSO for the final 24 hr of the incubation. During the isotopic pulse, all newly synthesized
proteins can only incorporate the K4R6 or K8R10 forms of Lys and Arg. Total cell lysates
were prepared from the two treatment groups and mixed in a 1:1 mass ratio prior to isolation
of subcellular fractions. Following mass spectrometric analysis, the abundance ratio of a K4/
K8 or R6/R10 peptide reflects the difference in translation of the associated protein due to
KU-32 treatment under hyperglycemic conditions (Table 1). Since all the K0R0 peptides
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associated with a given protein are present prior to the pulse, they can be ignored as they do
not represent newly translated protein19.
MaxQuant identified 743 proteins, of which 577 were identified by at least 2 peptides and
280 were quantified (Supplementary Table 1). Approximately one-third of the 280
quantified proteins were present in all of the treatments (Fig. 3A) and of the 156 proteins
annotated as mitochondrial, 79 were quantified. Though the log 2 distributions of the protein
expression ratios for each treatment were relatively unimodal, they were asymmetric and
consistent with hyperglycemia decreasing protein translation and KU-32 treatment of
hyperglycemically stressed cells increasing translation (Fig. 3B). To determine what
biological processes may be over-represented following KU-32 treatment, proteins showing
at least a 1.5 fold increase were submitted to enrichment analysis using DAVID and the
BinGO plug-in of Cytoscape. Both analyses supported that protein folding and response to
reactive oxygen species were among the enriched biological processes identified (both ~ 11
fold enrichment).
KU-32 Effects Expression of Multiple Molecular Chaperones
The effect of hyperglycemia in absence and presence of KU-32 treatment on the expression
of chaperones (green) and proteins with a mitochondrial annotation (red) is shown in Fig.
3C. We have shown previously that KU-32 induces cytosolic Hsp7013 and rather
unexpectedly, we did not detect this Hsp70 paralog in any treatment group. This may be due
to its relatively low abundance in the neurons compared to the constitutive form of Hsp70
(Hsc70), which is highly abundant and has a similar molecular weight (Fig. 3D). Although
an enriched mitochondrial preparation was used in the analysis, cytosolic Hsc70 was among
the top ten identifications based on total number of peptides identified, but was not
significantly modified in any treatment. However, immunoblot analysis of whole cell lysates
revealed that KU-32 significantly increased Hsp70 expression in hyperglycemically stressed
neurons (Fig. 3D).
A surprising finding of the pSILAC analysis was that KU-32 also increased mitochondrial
chaperones under hyperglycemic conditions. Hsp60 is necessary to ensure the proper folding
of proteins imported into the mitochondrial matrix38 and compared to hyperglycemia alone,
KU-32 promoted a median increase in translation of 3.7-fold (Fig 3C). An example of a
pSILAC isotopic triplet of mtHsp60 is shown in Fig. 4A. As expected, the unlabeled
AAVEEGIVIGGGCAII(R0) peptide is of substantially greater intensity than the newly
translated labeled peptides (note 5X scale amplification for the K4R6 and K8R10 peaks)
since it existed prior to the pulse and its intensity has additive contributions from sample
mixing. When comparing the R6 and R10 forms of the peptide as indicative of newly
translated protein, KU-32 treatment (R6 peptide at m/z 845.97) clearly enhanced the
translation of Hsp60 relative to hyperglycemia alone (note that the mass differences between
the peaks are one-half the expected amu shift since the peptides are doubly charged). In
contrast, Hsp10 is a mitochondrial chaperone that was identified but not quantified in any
treatment, suggesting that it had a lower rate of translation.
Mortalin/Grp75/stress-70 protein is a mitochondrial Hsp70 (mtHsp70) family member that
is a component of the presequence translocase-associated motor complex39 and its
translation was modestly decreased by hyperglycemia. Similar to Hsp60, the identification
of mtHsp70 was by numerous peptides in each treatment. Fig. 4B shows the MS/MS spectra
of a peptide that was identified by seven sequential y- and b-ions that KU-32 increased
about 1.8-fold in cells subjected to hyperglycemic stress (Fig. 4C). Importantly, immunoblot
analysis from 3 separate neuronal cultures further verified this finding (Fig. 4C). In contrast
to Hsp60, mtHsp70 is not induced as part of the classic heat shock response, however, it is
upregulated in response to other forms of cell stress and its over-expression can improve
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mitochondrial function during focal ischemia40. Additionally, about 99% of mitochondrial
proteins are nuclear encoded and require translocation and import into the organelle39.
Although little is known on the effect of diabetes on mitochondrial protein import in sensory
neurons, diabetes decreased the rate of protein import into interfibrillar, but not
subsarcolemmal cardiac mitochondria7. Since mtHsp70 and Hsp60 are respectively involved
in the import and folding of proteins into the mitochondrial matrix38, these data suggest that
KU-32 may affect mitochondrial function by facilitating protein import and maturation.
KU-32 also promoted a 4.9-fold increase in the expression of another Hsp70 paralog, Hsp70
protein 12A (Hsp70 p12A), and this was verified by immunoblot analysis of separate
neuronal cultures (Fig. 4D). Hsp70 p12A is an atypical member of the Hsp70 family and
despite the fact that HSPA12 genes evolved early in the evolution of vertebrates41, the
protein’s localization and function remain poorly characterized. Recent reports have
provided descriptions that Hsp70 p12A expression is decreased in pre-frontal cortex of
schizophrenic brain42 and increased in artherosclerotic lesions43, but no functional
properties were ascribed to these observations. Since Hsp70 p12A contains atypical ATPase
and substrate binding domains41, it may function as a co-chaperone.
Neither Hsp90α nor Hsp90β were significantly altered by KU-32 in the hyperglycemic
neurons. Curiously, KU-32 induced a 1.5-fold increase in calnexin translation, which is a
chaperone involved in protein quality control in the endoplasmic reticulum (ER). However,
other ER chaperones such as Grp78 and Grp94 were readily identified by numerous peptides
but not quantified, suggesting that they were not undergoing substantial changes in
translation. Together, these data support that in hyperglycemically stressed neurons,
inhibiting the C-terminus of Hsp90 is sufficient to increase several Hsp70 family members
and other mitochondrial chaperones.
KU-32 Increased MnSOD Translation and Decreased Glucose-induced Superoxide
Production
An established hallmark of mitochondrial dysfunction in DPN is the induction of oxidative
stress, due in part to an increase in mitochondrial superoxide production4. Consistent with
these data and our previous results18, translation of MnSOD in hyperglycemically stressed
neurons was about 50% less than that measured in control neurons (3 peptides quantified)
and KU-32 promoted a 2.3 fold increase in the translation of MnSOD (Fig. 5A) in the
hyperglycemically stressed cells. Although only quantified by 2 peptides, the identification
of this doubly charged peptide was substantiated by a sequential series of 10 b-ions and 11
y-ions (Fig. 5B). Moreover, immunoblot analysis of separate neuronal cultures verified that
hyperglycemia decreased MnSOD and that KU-32 treatment significantly increased its
expression (Fig. 5A).
To determine if the increase in MnSOD by KU-32 corresponded to a decrease in superoxide
production, the ratio of ethidium/dihydroethidium was used as a non-organelle selective
measure of superoxide. Neurons were pre-treated with vehicle or KU-32 and exposed to 45
mM glucose for 6 hrs to acutely increase superoxide levels22. Hyperglycemia increased
superoxide levels and KU-32 significantly blocked this effect (Fig. 5C). To determine if
KU-32 prevented superoxide production within mitochondria in neurons subjected to the
more chronic hyperglycemic stress that was used in the proteomic analyses, we used
MitoSox red and the mitochondrial marker, MitoTracker Green. Five days of hyperglycemia
increased mitochondrial superoxide levels and treating the cells with KU-32 for the final 24
hrs significantly decreased this response (Figs. 5D & 5E). As a positive control, some
neurons were treated with antimycin A prior to the addition of the dyes. These data support
that modulating the activity of Hsp90 with KU-32 is sufficient to increase MnSOD and
decrease glucose-induced mitochondrial oxidative stress.
Zhang et al. Page 8













Increased Translation of Mitochondrial Chaperones and MnSOD by KU-32 Correlates with
an Improved Bioenergetic Profile
Hyperglycemia-induced oxidative stress renders mitochondrial proteins more susceptible to
oxidative damage. Relative to their rate of production, a slower rate of repair by
mitochondrial chaperones favors accumulation of oxidatively damaged proteins in the
organelle44. Thus, the ability of KU-32 to increase mitochondrial chaperones and decrease
oxidative stress suggests that the bioenergetic profile of the organelle may also be enhanced.
To this end, we used a XF96 Extracellular Flux Analyzer to assess the effect of
hyperglycemia and KU-32 treatment on oxygen consumption rat (OCR). The XF96 analyzer
measures OCR in real time using intact cells and results in Fig. 6A show a typical
mitochondrial function experiment from ~5,000 sensory neurons per well (n=4) respiring in
DMEM containing 5.5 mM glucose. The first four rates represent basal OCR (light blue
shading) and each rate measure was normalized to the total amount of protein per well and
expressed as a percent of the final basal OCR (rate 4). Measuring OCR in intact cells in the
absence and presence of respiratory chain poisons is the single most useful test to stringently
assess mitochondrial dysfunction36. Oligomycin is an ATP synthase inhibitor and its
injection decreases the basal OCR. The magnitude of this decrease is indicative of the
percent of the basal OCR that is coupled to ATP synthesis (dark blue shading) and the
residual OCR is due to proton leak (uncoupled respiration). FCCP is a protonophore whose
addition provides a measure of maximal respiratory capacity (MRC, red shading). MRC
assesses the functional integrity of the respiratory chain since electron transfer is no longer
rate limited by the proton gradient across the inner mitochondrial membrane36. Nicholls has
defined spare respiratory capacity (SRC) as the arithmetic difference between MRC and the
basal OCR (pink shading)45. SRC provides a functional indication of how close to its
bioenergetic limit a cell is respiring36. A loss of SRC, especially in neurons that have
variable ATP demands, limits their ability to match energetic needs to environmental
demands and renders the cells more susceptible to secondary stressors46, 47. Thus, treatment-
induced differences in MRC and SRC are indicative of mitochondrial dysfunction affecting
the bioenergetic limits and reserve capacity of the neurons. Although not measured in the
current experiment, the green shading is representative of non-mitochondrial OCR values
obtained the presence of rotenone and antimycin A to inhibit complexes I and III,
respectively.
Neurons were incubated in medium containing 25 or 45 mM glucose for 5 days and treated
with KU-32 for the final 24 hrs. To assess respiration under a standard glucose
concentration, the cells were placed in serum-free DMEM containing 5.5 mM glucose and 1
mM pyruvate at 37°C for 1 hr prior to measuring OCR. After measuring basal OCR, the
cells were exposed to oligomycin and no significant differences were observed in the
magnitude of ATP-coupled OCR and proton leak (Fig. 6B). In contrast, though FCCP
stimulated MRC above basal OCR in all treatments, neurons exposed to hyperglycemic
stress exhibited a significantly blunted MRC relative to control cells (Fig. 6B). Similarly,
SRC was also significantly decreased in the glycemically stressed cells compared to control
(Fig. 6C, solid bars).
In cells maintained in 25 mM glucose and treated with KU-32, the average MRC and SRC
was slightly decreased but this was not significantly different from control. Consistent with
the efficacy of KU-32 in decreasing mitochondrial superoxide levels, glycemically stressed
cells treated with the drug showed a significant improvement in both MRC (Fig. 6B) and
SRC (Fig. 6C, solid bars) compared to the neurons incubated in high glucose alone. The
blunted MRC and SRC apparent in the hyperglycemically stressed cells supports that they
are energetically stressed and that mitochondrial workload is increased.
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The respiratory state apparent (Stateapp) provides a quantitative indication of mitochondrial
workload and can be estimated from these data47. As mitochondrial workload decreases,
Stateapp approaches 4, a metabolic indicator that minimal ATP-coupled respiration is needed
and OCR is primarily uncoupled47. On the other hand, high ATP demand requires state 3.0
respiration (comparable to that induced by FCCP, Fig. 6B). The Stateapp values were
3.5±0.5 and 3.5±0.3 in neurons treated with vehicle or KU-32, respectively, indicating the
basal mitochondrial workload required to meet ATP needs. In contrast, hyperglycemia
promoted a significant decrease in Stateapp (3.3±0.3, Fig. 6C, striped bars), suggesting that
ATP demand is depleting reserve capacity and that the organelles are approaching
bioenergetic failure37. Importantly, KU-32 treatment significantly improved this decline.
The ability of KU-32 to increase MRC, SRC and Stateapp supports that the cells have
recovered significant respiratory capacity that correlates with the induction of mitochondrial
chaperones and a decrease in superoxide production. Although numerous factors contribute
to OCR37, hyperglycemia-induced damage to respiratory chain proteins may decrease the
efficiency of electron transport to affect SRC and increase mitochondrial workload.
Conclusions
Our previous work on novobiocin-based C-terminal Hsp90 inhibitors has demonstrated that
they induce Hsp70 and protect cortical and sensory neurons from toxicity induced by β-
amyloid peptides and hyperglycemia, respectively13, 15. Although the neuroprotective
efficacy of KU-32 in reversing DPN required the presence of Hsp70, the current study
sought to unbiasedly identify whether KU-32 promoted the translation of other proteins that
may aid sensory neurons in tolerating glucotoxic stress48. Using pSILAC, we identify that
mitochondrial chaperones and MnSOD are also increased by KU-32 treatment of
hyperglycemically stressed cells. Consistent with the induction of MnSOD, KU-32
decreased mitochondrial superoxide levels in neurons subjected to 5 days of hyperglycemia.
Similarly, hyperglycemia decreased various measures of mitochondrial respiratory capacity
and treating the neurons with KU-32 significantly improved both maximum and spare
respiratory capacity.
Previous investigators have shown that embryonic sensory neurons cultured in vitro for 3
days are susceptible to glucose-induced apoptosis49, 50. However, 2–3 week old cultures of
embryonic sensory neurons are resistant to glucose-induced cell death11, 17, similar to adult
sensory neurons51. Although the more differentiated embryonic neurons can serve as a cell
model to examine mechanisms of hyperglycemic stress unrelated to apoptosis, their
response to hyperglycemia does not necessarily mimic that observed in adult neurons. For
example, hyperglycemia induced a robust increase in superoxide in adult sensory neurons
isolated from chronically diabetic mice but not from neurons obtained from control
animals18, 52. Thus, obtaining sensory neurons from adult diabetic animals that have
received drug treatment will also be a beneficial approach toward dissecting the mechanism
of drug efficacy on improving mitochondrial function. Although correlative, since
mitochondrial function is clearly compromised in DPN18, 52, 53, the improved expression of
mitochondrial chaperones and enhanced respiratory capacity may at least partially underlie
the efficacy of KU-32 in reversing sensory hypoalgesia in diabetic mice15. We would like to
emphasize that our approach in using the differentiated embryonic neurons has no
implications on the role or relevance of glucose-induced apoptosis to DPN. The
neuroprotective properties of KU-32 in ameliorating DPN are unlikely to center on
preventing sensory neuron death since apoptosis has not been demonstrated as a key feature
in the development of DPN54, 5556.
It is important to note that Hsp70 is a necessary component of drug efficacy since gene
deletion of inducible forms of Hsp70 ablated the ability of KU-32 therapy to reverse several
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indices of experimental DPN11. However, this does not rule out that the induction of
mitochondrial chaperones and MnSOD are not a critical aspect of the effect of KU-32 on
improving mitochondrial function, and by extension, DPN. Emerging data supports that
diabetes increases oxidative stress and mitochondrial fission/fusion in sensory neurons 57–59.
Decreasing oxidative stress and maintaining the fidelity of protein import to support this
turnover would be essential to maximizing the bioenergetic capacity of the organelle. As
both Hsp70 and mtHsp70 aid mitochondrial protein import via separate import pathways39,
we hypothesize that these proteins may enhance mitochondrial bioenergetics by facilitating
the import of respiratory and anti-oxidant proteins; MnSOD is imported into the
mitochondrial matrix via mtHsp70. To this end, it will be critical to define whether the
necessity of Hsp70 induction for drug efficacy is related to improved mitochondrial function
and/or protein import. Similarly, the sufficiency/necessity of mtHsp70 and MnSOD
induction by KU-32 to improving mitochondrial function in response to hyperglycemic
stress remains to be determined.
In conclusion, the salient findings of this study provide proof-of-principle that a novel C-
terminal Hsp90 inhibitor can decrease mitochondrial superoxide levels and improve
organellar bioenergetics in hyperglycemically stressed neurons. These functional
improvements correlated with the translational induction of MnSOD and mitochondrial
chaperones by KU-32. Thus, the reported efficacy of KU-32 therapy in ameliorating sensory
hypoalgesia in DPN may relate to improved mitochondrial function.
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BinGO Biological Networks Gene Ontology
dFCS dialyzed fetal calf serum
DPN diabetic peripheral neuropathy
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ion trap Fourier transform ion cyclotron resonance tandem mass
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Figure 1. Hyperglycemia decreases the incorporation of [3H]Leucine into protein
Primary sensory neurons were cultured for 5 days in medium with 25 mM or 45 mM
glucose and treated with DMSO or 1 µM KU-32 for the final 24 hrs. Coincident with the
addition of KU-32, the cells were pulsed with 1 µCi/ml [3H]Leu and the incorporation of of
[3H]Leu into total protein was determined as described in Experimental Procedures. The
total dpm/µg protein was determined and the results are expressed as the percent of control.
The data are the mean ± SEM from three experiments. *, p< 0.05 compared to control, #, p <
0.05 compared to glucose minus KU-32.
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Figure 2. Experimental strategy for pSILAC analyses
Primary neurons were cultured in medium containing 45 mM glucose and light forms of Lys
and Arg (K0R0) for 3 days. The K0R0 cultures were divided in half and one set of cells was
placed in hyperglycemic culture solution containing medium-heavy forms of Lys and Arg
(K4R6). The cells were pulsed with K4R6 for 48 hrs and treated with 1 µM KU-32 for the
final 24 hr. The remaining K0R0 cells were placed in hyperglycemic culture medium
containing heavy isotope forms of Lys and Arg (K8R10) and treated with DMSO for the
final 24 hr of the incubation. Total cell lysates were prepared, mixed in a 1:1 mass ratio, a
heavy mitochondrial fraction isolated and the proteins separated by SDS-PAGE prior to
tryptic digestion and MS/MS analysis.
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Figure 3. Distribution of translationally induced proteins
A) Venn diagram of quantified proteins in each group. Numbers in parentheses are total
number of quantified proteins per treatment. Percent of unique and overlapping proteins are
shown within the colored sections of the diagram. B) The non-normalized protein expression
ratios provided by MaxQuant were log 2 transformed, binned into 0. 5 units and the total
proteins per bin counted. C) The expression ratios of all quantified chaperones (green) and
mitochondrial proteins (red) detected in both the high glucose and high glucose + KU-32
treatments were plotted against each other. D) Representative immunoblot and quantitation
of Hsp70 levels from three separate neuronal cultures. *, p< 0.05 compared to control, #, p <
0.05 compared to glucose minus KU-32.
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Figure 4. KU-32 induces the translation of Hsp60 and Hsp70 family members in hyperglycemic
neurons
Primary neurons were incubated in medium containing 25 mM or 45 mM glucose for 3 days
and pulsed with either K4R6 or K8R10 Lys/Arg for an additional 48 hrs. The cultures were
treated with 1 µM KU-32 (K4R6) or DMSO (K8R10) for the final 24 hrs of the incubation.
Cell lysates were prepared, mixed in a 1:1 ratio and the samples processed for MS/MS
analysis. (A) Representative MS scan showing an increase in Hsp60 in hyperglycemic
neurons treated with KU-32 (R6 peptide) compared to glucose only (R10 peptide). Note the
5× scale amplification to demonstrate the increase in the R6 peptide compared to the R10
peptide. (B) MS/MS spectrum of the SQVFSTAADGQTQVEIK peptide of mtHsp70. The
majority of the un-annotated peaks arise from the loss of water and ammonia ion but their
labeling was omitted for clarity. The asterisk indicates a peak that was unassigned. (C)
Representative MS scan showing an increase in mtHsp70 in hyperglycemic neurons treated
with KU-32 (K4 peptide) compared to glucose only (K8 peptide); 5× scale amplification as
discussed above. A representative immunoblot and quantitation (n=3) of the effect of
hyperglycemia and KU-32 on mtHsp70 expression is shown to the right of the spectrum. (D)
Representative MS scan showing an increase in Hsp70 p12A in hyperglycemic neurons
treated with KU-32 (K4 peptide) compared to glucose only (K8 peptide); 5× scale
amplification as discussed above. A representative immunoblot and quantitation (n=3) of the
effect of hyperglycemia and KU-32 on Hsp70 p12A expression is shown to the right of the
spectrum. *, p< 0.05 compared to control, #, p < 0.05 compared to glucose minus KU-32.
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Figure 5. KU-32 induces the translation of MnSOD and decreases mitochondrial superoxide
Hsp70 in hyperglycemic neurons
Primary neurons were incubated in medium containing 25 mM or 45 mM glucose for 3 days
and pulsed with either K4R6 or K8R10 Lys/Arg for an additional 48 hrs. The cultures were
treated with 1 µM KU-32 (K4R6) or DMSO (K8R10) for the final 24 hrs of the incubation.
Cell lysates were prepared, mixed in a 1:1 ratio and the samples processed for MS/MS
analysis. (A) Representative MS scan showing an increase in MnSOD in hyperglycemic
neurons treated with KU-32 (R6) compared to glucose only (R10). Note the 5× scale
amplification to demonstrate the increase in the R6 relative to R10 peptide. A representative
immunoblot and quantitation (n=3) of the effect of hyperglycemia and KU-32 on MnSOD
expression is shown to the right of the spectrum. (B) MS/MS spectrum of the
AIWNVINWENVSQR peptide. The majority of the un-annotated peaks arise from the loss
of water and ammonia ion but their labeling were omitted for clarity. The asterisk indicates a
peak that was unassigned. (C) Effect of KU-32 on decreasing glucose-induced superoxide
production as measured using the ratio of ethidium/dihyroethidine. Results are expressed as
a fold control and are the mean±SEM from three separate cultures. Gluc; 45 mM glucose.
(D) Representative images showing that KU-32 decreased glucose-induced mitochondrial
superoxide production as visualized using MitoSox Red. Neurons were co-stained with
Mitotracker Green to localize mitochondria. Grey panels show raw grey scale images that
were exported prior to being colorized in Image J. Cells treated with antimycin A (Ant)
served as a positive control for superoxide generation. (E) Quantitative image analysis from
three separate neuron cultures. *, p< 0.05 compared to control, #, p < 0.05 compared glucose
minus KU-32.
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Figure 6. Hyperglycemia decreased mitochondrial bioenergetics which was reversed by KU-32
treatment
(A) Example of a mitochondrial function experiment in the XF96 extracellular flux analyzer.
Basal OCR (light blue) is given by the first four rate measures. The addition of 1 µg/ml
oligomycin inhibits ATP synthase and the decrease in OCR gives a measure of ATP-coupled
respiration (dark blue). Residual OCR in the presence of oligomycin provides a measure of
proton leak (orange). The addition of 1 µM FCCP dissipates the proton gradient across the
inner mitochondrial membrane and assesses maximal respiratory capacity (MRC, red).
Spare respiratory capacity (SRC, pink) is assessed as the difference between MRC and the
basal OCR. The green shading represents the estimated contribution of non-mitochondrial
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respiration to basal OCR but was not directly measured in the experiment shown. (B)
Primary neurons were seeded into a 96 well plate and incubated in medium containing 25
mM or 45 mM glucose for 5 days and treated with 1 µM KU-32 or DMSO for the final 24
hrs. The cells were placed in medium containing 5 mM glucose and 1 mM pyruvate prior to
the respiratory measures. Results shown are the mean±SEM from 5–8 wells per treatment
from one experiment repeated three times. Arrows indicate the injection of oligomycin and
FCCP. Hyperglycemia induced a significant decrease in MRC relative to control neurons (*,
p< 0.05) and KU-32 treatment significantly increased MRC compared to cells treated with
high glucose only (#, p< 0.001). (C) Hyperglycemia significantly decreased SRC (*, p<
0.05, left axis and solid bars) and Stateapp (*, p< 0.01, right axis and striped bars) compared
to control cells. Both SRC (#, p< 0.001) and Stateapp (#, p< 0.05) were significantly
improved by KU-32 treatment compared to cells treated with high glucose alone.
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Table 1
Isotopic Combinations for pSILAC Experiments
Label
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